Suppr超能文献

体重指数对接受肾切除术患者的肿瘤学和手术结果的影响:系统评价和荟萃分析。

The impact of body mass index on oncological and surgical outcomes of patients undergoing nephrectomy: a systematic review and meta-analysis.

机构信息

Department of Urology, National University Hospital, National University Health System, Singapore, Singapore.

S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

BJU Int. 2023 Dec;132(6):608-618. doi: 10.1111/bju.16103. Epub 2023 Jul 4.

Abstract

OBJECTIVE

To perform a systematic review and meta-analysis to evaluate the impact of body mass index (BMI) on oncological (primary) and surgical (secondary) outcomes of patients who underwent nephrectomy, as obesity or high BMI is a known risk factor for renal cell carcinoma (RCC) and predictor of poorer outcomes.

METHODS

Studies were identified from four electronic databases from database inception to 2 June 2021, according to the Preferred Reporting Items for Systematic Review and Meta-analysis statement. The review protocol was registered in the International Prospective Register of Systematic Reviews with the identification number: CRD42021275124.

RESULTS

A total of 18 studies containing 13 865 patients were identified for the final meta-analysis. Regarding oncological outcomes, higher BMI predicted higher overall survival (BMI >25 vs BMI <25 kg/m : hazard ratio [HR] 0.70, 95% confidence interval [CI] 0.58-0.85), cancer-specific survival (BMI >25 vs BMI <25 kg/m : HR 0.60, 95% CI 0.50-0.73; BMI 25-30 vs BMI <25 kg/m : HR 0.46, 95% CI 0.23-0.95; BMI >30 vs BMI <25 kg/m : HR 0.50, 95% CI 0.36-0.69), and recurrence-free survival rates (BMI >25 vs BMI <25 kg/m : HR 0.72, 95% CI 0.63-0.82; BMI 25-30 vs BMI <25 kg/m : HR 0.59, 95% CI 0.42-0.82). Those with a lower BMI fared better in surgical outcomes, such as operation time and warm ischaemic time, although the absolute difference was minimal and unlikely to be clinically significant. There was no difference between groups for length of hospital stay, intraoperative or postoperative complications, blood transfusion requirements, and conversion to open surgery.

CONCLUSION

Our study suggests that a higher BMI is associated with improved long-term oncological survival and similar perioperative outcomes as a lower BMI. More research into the underlying biological and physiological mechanisms will enable better understanding of the effect of BMI, beyond mere association, on post-nephrectomy outcomes.

摘要

目的

进行系统评价和荟萃分析,以评估体重指数(BMI)对接受肾切除术患者的肿瘤学(主要)和手术(次要)结局的影响,因为肥胖或高 BMI 是肾细胞癌(RCC)的已知危险因素,也是预后不良的预测因素。

方法

根据系统评价和荟萃分析首选报告项目的声明,从四个电子数据库中检索从数据库建立到 2021 年 6 月 2 日的研究。审查方案在国际前瞻性系统评价注册处进行了注册,识别号为:CRD42021275124。

结果

最终荟萃分析共纳入了 18 项包含 13865 名患者的研究。关于肿瘤学结果,较高的 BMI 预测总体生存率更高(BMI>25 与 BMI<25kg/m2:风险比[HR]0.70,95%置信区间[CI]0.58-0.85),癌症特异性生存率(BMI>25 与 BMI<25kg/m2:HR 0.60,95%CI 0.50-0.73;BMI 25-30 与 BMI<25kg/m2:HR 0.46,95%CI 0.23-0.95;BMI>30 与 BMI<25kg/m2:HR 0.50,95%CI 0.36-0.69)和无复发生存率(BMI>25 与 BMI<25kg/m2:HR 0.72,95%CI 0.63-0.82;BMI 25-30 与 BMI<25kg/m2:HR 0.59,95%CI 0.42-0.82)。那些 BMI 较低的患者在手术结果方面表现更好,例如手术时间和热缺血时间,尽管绝对差异很小,不太可能具有临床意义。两组在住院时间、术中或术后并发症、输血需求以及转为开放性手术方面没有差异。

结论

我们的研究表明,较高的 BMI 与改善长期肿瘤学生存和类似的围手术期结局相关,而 BMI 较低则不然。对 BMI 对肾切除术后结果的影响的潜在生物学和生理学机制进行更多研究,将有助于更好地理解 BMI 的影响,而不仅仅是关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验